|
LRRC47 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44819999999368E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.21589999999506E-05 |
| Normal-vs-Stage2 |
1.332620E-01 |
| Normal-vs-Stage3 |
1.99918000000077E-05 |
| Normal-vs-Stage4 |
1.63051999999553E-05 |
| Stage1-vs-Stage2 |
7.381900E-02 |
| Stage1-vs-Stage3 |
3.794400E-01 |
| Stage1-vs-Stage4 |
2.310000E-01 |
| Stage2-vs-Stage3 |
3.249800E-02 |
| Stage2-vs-Stage4 |
2.360000E-02 |
| Stage3-vs-Stage4 |
6.283800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.75653999999748E-05 |
| Normal-vs-AfricanAmerican |
2.027800E-01 |
| Normal-vs-Asian |
2.010600E-04 |
| Caucasian-vs-AfricanAmerican |
9.997800E-02 |
| Caucasian-vs-Asian |
9.407200E-01 |
| AfricanAmerican-vs-Asian |
1.178020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.414200E-04 |
| Normal-vs-Female |
3.60150000000559E-05 |
| Male-vs-Female |
9.600800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.58489999999767E-05 |
| Normal-vs-Age(41-60Yrs) |
1.230750E-04 |
| Normal-vs-Age(61-80Yrs) |
1.391060E-04 |
| Normal-vs-Age(81-100Yrs) |
2.901500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.663200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.031600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.758000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.117000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.542800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.398000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.002000E-04 |
| Classical-VS-Follicular |
7.262600E-01 |
| Classical-VS-Other |
1.987000E-01 |
| Classical-VS-Normal |
1.632800E-04 |
| Tall-VS-Follicular |
1.143530E-02 |
| Tall-VS-Other |
8.756400E-01 |
| Tall-VS-Normal |
7.93029999446304E-08 |
| Follicular-VS-Other |
4.024200E-01 |
| Follicular-VS-Normal |
1.522800E-03 |
| Other-VS-Normal |
8.861800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.562500E-04 |
| Normal-vs-N1 |
3.23049997863478E-09 |
| N0-vs-N1 |
3.790800E-04 |
|
|
